Bristol-Myers Squibb to Announce Results for Second Quarter 2010 on July 22

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will announce results for the second quarter of 2010 on Thursday, July 22, 2010. During a conference call at 10:30 a.m. EDT on July 22, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing 913-981-5597, confirmation code: 3687148. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. EDT on July 22 through midnight EDT on August 5, 2010. The replay will also be available through http://investor.bms.com or by dialing 402-280-9013, confirmation code: 3687148.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.



CONTACT:

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
[email protected]
or
Investors:
John Elicker, 609-252-4611
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Hospitals  Pharmaceutical  Professional Services  Finance  Research  Science  General Health

MEDIA:

Logo
 Logo

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.